Navigation Links
Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
Date:8/17/2010

CRANBURY, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today announced positive results of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD). The results demonstrate that with subcutaneous administration consistent therapeutic blood plasma levels can be obtained without sustained clinically significant blood pressure effects and support the continued development of bremelanotide.

As part of the analysis of the effects of bremelanotide on blood pressure, the Company engaged an independent panel of cardiovascular experts to evaluate both study results and an integrated cardiovascular safety analysis conducted on data from completed bremelanotide studies. Based on recommendations from the outside panel and its own internal review, Palatin intends to engage the Food and Drug Administration (FDA) in discussions regarding clinical trial designs to further study bremelanotide for the treatment of sexual dysfunction.

Palatin expects to meet with the FDA in the fourth quarter of calendar year 2010 to discuss initiation of a Phase 2 study of subcutaneously administered bremelanotide, as a monotherapy and as a combination therapy with a PDE-5 inhibitor such as sildenafil (Viagra®), for men with ED who are not responsive or inadequately responsive to PDE-5 inhibitor therapies alone.  

The objective of the placebo-controlled, randomized, double-blind, cross over safety study was evaluation of blood pressure effects of subcutaneous bremelanotide in healthy male volunteers between 45 and 65 years old.  The study also evaluated dose-to-dose consistency of plasma exposure of bremelanotide.  A total of 49 subjects were dosed in the safety study; nineteen of the subjects were enro
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
2. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
3. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
4. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
5. Palatin Technologies to Present at 8th Annual BIO Investor Forum
6. Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
7. Palatin Technologies, Inc. To Raise $2.6 Million Dollars in Registered Direct Offering
8. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... CHAPEL HILL, N.C. , May 22, 2015 ... is critical to pharmaceutical brand recognition and success. ... Practices, LLC conducted a study to provide pharmaceutical ... level of investment (FTEs and budget) that are ... companies. Pharmaceutical and biotech marketing managers can utilize ...
(Date:5/22/2015)... May 22, 2015 The leading companies ... billion global cardiac rhythm management device market dominate ... that Medtronic, St. Jude Medical, Boston Scientific and ... this market segment. The healthcare market research publisher,s ... uses 2015 as a base year, providing forecasts ...
(Date:5/22/2015)... OF PRUSSIA, Pa. , May 22, 2015  The ... Behring its 2015 Corporate Leadership Award as recognition for ... improving the care of the bleeding disorders community.  The award ... Director, CSL Limited, during the NHF Annual Spring Soiree in ... "The National Hemophilia Foundation is dedicated to finding ...
Breaking Medicine Technology:Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4
... 2012 The American Pharmacists Association (APhA), a DC-based, ... of pharmacy, announced that on Monday evening, May ... was attacked and defaced by an unknown individual ... ) APhA considers any attack ...
... the House passed H.R. 5651, its version of the ... provisions to mitigate drug shortages, most notably mandating an ... largest professional society concerned with the causes and treatment ... specialize in blood cancers such as leukemia, lymphoma, and ...
Cached Medicine Technology:American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA) 2
(Date:5/22/2015)... 2015 Hands On HealthCare Massage Therapy ... the Annual One Day Sale on Massage and ... HCMT offers drastically reduced certificates one day a year. This ... sessions, through what used to be the slowest time of ... community as well. This once a year occurrence has become ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Family, friends, ... Hospital’s world-renowned surgical oncologist, Dr. LaSalle D. Leffall, on ... The luncheon began after Grand Rounds in the hospital’s ... waited anxiously outside the auditorium, trying to keep the ... but if he sees me, he’ll know something is ...
(Date:5/22/2015)... Coordinating care for people with complex, ... have not been reimbursed or rewarded for care ... has paved the way by offering reimbursement for ... of Oculus Health , an innovative care ... platform will now be able to easily engage ...
(Date:5/22/2015)... According to a new Aegis Living Study on Attitudes ... to worry about what will happen to their memory as ... Silent Generation), which may help explain why nearly half of ... Millennials (47%), Gen X’ers (51%), and Boomers (43%). The study ... more than 2,000 U.S. adults ages 18+. , “This ...
(Date:5/22/2015)... Coco Libre, the Official Coconut Water of ... at the 104th running of the race. On Sunday, May ... 315 people in one hour—one person about every 10 seconds. ... true to the heart of the Bay Area, so unique, ... to the finish line only made sense,” said Jennifer Goodrum, ...
Breaking Medicine News(10 mins):Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2
... have found that obese persons are at higher risk as ... ,Multiple myeloma or Kahler's disease is a type of ... bone marrow that produce antibodies. Its prognosis, despite therapy, is ... transplant. ,The joint study was conducted by a ...
... with a form of leukaemia boosts their chances of survival ... published in next Saturday's Lancet. ,In general, ... survival -- about 80 percent today, compared with only 10 ... drops significantly in infants aged under 12 months, where it ...
... went a little wild at a club. ,The ... in Bucharest, Romania after a gig and spent a whopping amount ... girls in his party so he reportedly asked where the women ... most expensive beverages and a group of girls who arrived after ...
... revealed that the reason behind her battle with Insomnia is her ... she is struggling with the sleep disorder, because her songs keep ... most of her lyrics and hits strike her when she's trying ... has to write them down or record them on the spot, ...
... has created history by successfully conducting a unrelated bone ... the cord blood cells from an American donor, at ... ,Howard Kafeero from Uganda suffered from Fanconi ... fatal. Seven months ago, he was brought to the ...
... raise awareness of maritime pollution and secure a place in ... the Pacific Ocean from San Francisco on Thursday. ... in her lightweight 24-foot (seven meter) silver rowing boat and ... kilometer) trek across the vast expanse of the Pacific. ...
Cached Medicine News:Health News:Obesity, a Risk Factor for Developing Multiple Myeloma 2Health News:Chennai Hospital Conducts Bone Marrow Transplantation Successfully 2Health News:Briton Set for Pacific Solo Odyssey to Highlight Warming 2
... Semi-Automatic Tissue Sectioning System has maintained the ... system. Researchers from around the globe have ... their fresh and fresh fixed tissue sectioning ... With the Vibratome Automatic Tissue Sectioning Systems, ...
... The Vibratome 1000 Plus Sectioning System provides ... fixed, animal, or plant tissues. The ... allows sectioning without freezing or embedding. ... morphology, the destruction of enzyme activities, and ...
... Vibratome comes standard with a square ... blocks are utilized for mounting specimens ... vice. The blocks are annodized ... can be reused. They are ...
This is a perfect tool for retrieving free floating sections from the Vibratome bath....
Medicine Products: